Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological Features.

CalabrĂ² M, Porcelli S, Crisafulli C, Wang SM, Lee SJ, Han C, Patkar AA, Masand PS, Albani D, Raimondi I, Forloni G, Bin S, Cristalli C, Mantovani V, Pae CU, Serretti A.

J Mol Neurosci. 2018 Jan;64(1):62-74. doi: 10.1007/s12031-017-1002-1. Epub 2017 Nov 21.

PMID:
29164477
2.

Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis.

Watanabe Y, Nunokawa A, Kaneko N, Shibuya M, Egawa J, Someya T.

Schizophr Res. 2012 Nov;141(2-3):279-80. doi: 10.1016/j.schres.2012.06.043. Epub 2012 Jul 19. No abstract available.

PMID:
22818711
3.

The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex.

Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Umeda-Yano S, Kamino K, Ikezawa K, Azechi M, Iwase M, Kazui H, Kasai K, Takeda M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1309-15. doi: 10.1016/j.pnpbp.2011.04.008. Epub 2011 Apr 28.

PMID:
21549171
4.

Lack of association between sigma receptor gene variants and schizophrenia.

Satoh F, Miyatake R, Furukawa A, Suwaki H.

Psychiatry Clin Neurosci. 2004 Aug;58(4):359-63.

5.

No association between the sigma receptor type 1 gene and schizophrenia: results of analysis and meta-analysis of case-control studies.

Uchida N, Ujike H, Nakata K, Takaki M, Nomura A, Katsu T, Tanaka Y, Imamura T, Sakai A, Kuroda S.

BMC Psychiatry. 2003 Oct 21;3:13.

Supplemental Content

Loading ...
Support Center